Nanologica AB (publ)
Nasdaq Stockholm · LEI 54930017L41C7P87LP22· Fiscal year 2025
Staff cost per employee
Not disclosed
Employees
Not disclosed
Quick read
- Revenue grew 45.3% year over year.
- Operating loss of $4.6M in 2025.
Last 3 years
Revenue
Operating income
See the share price on Google Finance ↗
Investor metrics
2025
- Operating margin
- -221.5%
- Net margin
- -242.8%
- ROE
- -226.5%
- Debt-to-equity
- 289.1%
- Equity ratio
- 25.7%